Relacorilant is a selective glucocorticoid receptor antagonist initially investigated for hypercortisolism and later developed as a sensitizing agent in oncology. It is an active pharmaceutical ingredient used in combination with other agents for certain resistant cancers.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1496510-51-0
Ahu-377 sodium
pharmaceutical raw material
Sacubitril
pharmaceutical raw material
Alpha-Ethyl (alphaS,gammaS)-gamma-((3-carboxy-1-oxopropyl)amino)-alpha-methyl(1,1'-biphenyl)-4-pentanoate
pharmaceutical raw material
Clemastine fumarate
pharmaceutical raw material
[(4aR)-1-(4-fluorophenyl)-6-(1-methylpyrazol-4-yl)sulfonyl-4,5,7,8-tetrahydropyrazolo[5,4-g]isoquinolin-4a-yl]-[4-(trifluoromethyl)-2-pyridinyl]methanone
WANIDIGFXJFFEL-SANMLTNESA-N
CN1C=C(C=N1)S(=O)(=O)N2CCC3=CC4=C(C[C@@]3(C2)C(=O)C5=NC=CC(=C5)C(F)(F)F)C=NN4C6=CC=C(C=C6)F